New immunosuppressive agents in pediatric transplantation
Clinics, 2014 Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival.
Christina Nguyen, Ron Shapiro
doaj +1 more source
New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus [PDF]
Anais Brasileiros de Dermatologia, 2015 Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor.
Victor Pavan Pasin +5 more
doaj +1 more source
Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil [PDF]
Anais Brasileiros de Dermatologia, 2014 The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used.
Stephanie Del Rio Navarrete Biot +5 more
doaj +1 more source
Infiltrative cardiomyopathies. Report of a case of cardiac sarcoidosis
Iatreia, 2017 Sarcoidosis is characterized by the presence of non-caseating granulomas that may affect any organ. Heart involvement manifests as cardiomyopathy. Frequency of cardiac involvement in sarcoidosis is around 30 %, but only 5 % of such cases are symptomatic.
Muñoz-Ortiz, Édison +3 more
doaj +1 more source
Rituximab: A Magic Bullet for Pemphigus [PDF]
Journal of Clinical and Diagnostic Research, 2017 Introduction: Pemphigus, an autoimmune disease, was fatal before the era of corticosteroids. With the advent of steroids, mortality decreased but morbidity was present due to the side effects of high dose steroids.
V. Anandan +4 more
doaj +1 more source
Murine model for Fusarium oxysporum invasive fusariosis reveals organ-specific structures for dissemination and long-term persistence [PDF]
, 2014 Peer reviewedPublisher ...
A Di Pietro +45 more
core +3 more sources
Safety and effectiveness of mycophenolate mofetil associated with tacrolimus for liver transplantation immunosuppression: a systematic review and meta-analysis of randomized controlled trials [PDF]
Clinics, 2021 A combination of immunosuppressants may improve outcomes due to the synergistic effect of their different action mechanisms. Currently, there is no consensus regarding the best immunosuppressive protocol after liver transplantation.
Francisco Tustumi +11 more
doaj +1 more source
Statins as immunosuppressive agents [PDF]
Liver Transplantation, 2001 Abstract Unavailable. Please See Print Journal.
openaire +2 more sources
Inclusion body myositis: therapeutic approaches. [PDF]
, 2012 The idiopathic inflammatory myopathies are a heterogeneous group of diseases that include dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) and other less common myopathies.
Aggarwal, Rohit, Oddis, Chester V
core +1 more source
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation [PDF]
, 1994 Following rat heterotopic heart allotransplantation, low to lethal doses of the antimetabolites mizoribine (MIZ), RS-61443 (RS), and AZA were given alone or in combination with subtherapeutic doses of FK506 (0.04 mg/kg/day) for 14 days after ...
Fujisaki, S +6 more
core +1 more source